Advanced Wound Care Demand Will Unlock Global Opportunities

Published
02 Apr 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$30.67
43.4% undervalued intrinsic discount
15 Aug
US$17.35
Loading
1Y
-8.0%
7D
-7.6%

Author's Valuation

US$30.7

43.4% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 39%

Shared on24 Apr 25
Fair value Decreased 24%

AnalystConsensusTarget has increased shares outstanding growth rate from 0.1% to 0.2%.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 5.63%

AnalystConsensusTarget has decreased revenue growth from 30.0% to 25.9% and decreased shares outstanding growth rate from 0.2% to 0.1%.